Last $110.35 USD
Change Today +1.97 / 1.82%
Volume 63.5K
BIO On Other Exchanges
New York
New York
As of 8:04 PM 10/17/14 All times are local (Market data is delayed by at least 15 minutes).

bio-rad laboratories-a (BIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/21/14 - $134.13
52 Week Low
10/15/14 - $105.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-RAD LABORATORIES-A (BIO)

Related News

No related news articles were found.

bio-rad laboratories-a (BIO) Related Businessweek News

View More BusinessWeek News

bio-rad laboratories-a (BIO) Details

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

7,750 Employees
Last Reported Date: 03/18/14
Founded in 1952

bio-rad laboratories-a (BIO) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $810.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $423.3K
Chief Operating Officer
Total Annual Compensation: $577.0K
Executive Vice President of International Sal...
Total Annual Compensation: $406.7K
Compensation as of Fiscal Year 2013.

bio-rad laboratories-a (BIO) Key Developments

Bio-Rad Laboratories, Inc. Announces Executive Appointments

Bio-Rad Laboratories has appointed John Goetz as chief operating officer. In his new role Goetz is responsible for all operating functions of the company on a global basis, including the Clinical Diagnostics and Life Science segments as well as global sales. The company also announced that Mr. John Hertia was appointed as Executive Vice President and President of the Clinical Diagnostics Group. Mr. Hertia succeeds Mr. Goetz in leading the company's worldwide Clinical Diagnostics business. In addition, Ms. Shannon Hall was appointed Executive Vice President and President of the Life Science Group. Prior to this position, Ms. Hall was Vice President and General Manager of the Lab Separations Division in the Life Science Group. Mr. Goetz has been with Bio-Rad for 40 years and has served in various capacities throughout that time including Division Manager of Quality Systems and Group Operations Manager.

Bio-Rad Laboratories, Inc. Announces Exit of Bradford J. Crutchfield, Executive Vice President and President, Life Science Group

Effective August 26, 2014, Bradford J. Crutchfield, Executive Vice President and President, Life Science Group was no longer employed by Bio-Rad Laboratories, Inc. A replacement has not yet been appointed.

Bio-Rad Names Joel McComb to Board of Directors

Bio-Rad Laboratories reported that Joel McComb has been appointed to its Board of Directors. Since mid-2010 he founded three technology companies in the life science and diagnostics markets under the umbrella of Point Break Capital.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIO:US $110.35 USD +1.97

BIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $37.11 USD 0.00
BioMerieux €77.89 EUR +0.07
PerkinElmer Inc $40.00 USD -0.07
QIAGEN NV €17.15 EUR -0.073
Siemens Ltd 827.35 INR +31.40
View Industry Companies

Industry Analysis


Industry Average

Valuation BIO Industry Range
Price/Earnings 52.2x
Price/Sales 1.5x
Price/Book 1.4x
Price/Cash Flow 42.8x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-RAD LABORATORIES-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at